top of page
検索

Alpha Tau Medical (DRTS) rings the bell at NASDAQ

What a thrill to be with friends and colleagues at NASDAQ!

Congratulations to the entire Alpha Tau Medical team on its remarkable success in bringing hope and healing to patients with solid tumor cancers thought to be uncurable.

We at HekaBio K.K. are extremely grateful to be an early partner and investor in Alpha Tau. It’s our mission to keep advancing this technology in Japan.



Photography courtesy of Nasdaq, Inc.

最新記事

すべて表示

日経バイオテクのインタビュー記事について

12月12日に掲載されたRob Claarのインタビュー記事の転載許可をいただきました。 https://bizboard.nikkeibp.co.jp/bp_bto/atcl/news/p1/23/12/09/11391/?ST=p_bizboard&bzb_pt=0&BZB_DATE_TOKEN=3f267934ea6173d0f88d7508b660c24fc25a4b5eac051e65a

bottom of page